StockDoc Podcast: HeraMED’s telehealth offering for pregnant women is booming under COVID-19
Health & Biotech
share
Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast.
In this episode the good doctor sits down with Alexander Radke, general manager of HeraMED (ASX: HMD).
HeraMED is a technology startup developing a lineup of pregnancy monitoring solutions for home use.
The company’s current focus is on the pilot projects, beta testing and clinical trials for HeraCARE, a digital pregnancy monitoring platform.
HeraCARE is focused on improving prenatal care by using patient data to accurately monitor the pregnancy, predict potential scenarios and decrease the number of pre and post-natal complications.
So click below to hear the pair discuss the telehealth boom, HeraCARE and the coming year for HeraMED.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The StockDoc Podcast with Dr Nigel Finch and subscribe!
